Patents by Inventor Marcin Filutowicz

Marcin Filutowicz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11864559
    Abstract: The present disclosure relates to amoebae (slime molds) and uses thereof. In particular, the present disclosure relates to the use of amoebae or their environmentally stable spores to control agricultural infections and other uses.
    Type: Grant
    Filed: June 17, 2020
    Date of Patent: January 9, 2024
    Assignee: AmebaGone, LLC
    Inventors: Marcin Filutowicz, Ryan Kessens, Amy Jancewicz
  • Publication number: 20230040339
    Abstract: The present disclosure relates to amoebae (slime molds) and uses thereof. In particular, the present disclosure relates to the use of amoebae or their environmentally stable spores to control agricultural infections and other uses.
    Type: Application
    Filed: December 22, 2020
    Publication date: February 9, 2023
    Inventors: Marcin Filutowicz, Chad Hall, Amy Jancewicz
  • Publication number: 20210330715
    Abstract: The present disclosure relates to amoebae (slime molds) and uses thereof. In particular, the present disclosure relates to anti-biofilm components of amoebae to target biofilms.
    Type: Application
    Filed: April 22, 2021
    Publication date: October 28, 2021
    Inventors: Marcin Filutowicz, Dhanansayan Shanmuganayagam, Nathan James Chesmore
  • Publication number: 20200397003
    Abstract: The present disclosure relates to amoebae (slime molds) and uses thereof. In particular, the present disclosure relates to the use of amoebae or their environmentally stable spores to control agricultural infections and other uses.
    Type: Application
    Filed: June 17, 2020
    Publication date: December 24, 2020
    Inventors: Marcin Filutowicz, Ryan Kessens, Amy Jancewicz
  • Patent number: 8715641
    Abstract: The present invention relates to amoebae (slime molds) and uses thereof. In particular, the present invention relates to the use of amoebae or their environmentally stable spores to treat microbial infections and other uses.
    Type: Grant
    Filed: September 27, 2013
    Date of Patent: May 6, 2014
    Assignee: Amebagone, LLC
    Inventors: Marcin Filutowicz, Katarzyna Dorota Borys
  • Publication number: 20140056850
    Abstract: The present invention relates to Dictyostelids myxamoebae of phylum Mycetozoa and uses thereof. In particular, the present invention relates to the use of amoebae, slugs, or their environmentally stable spores to treat microbial infections and other uses.
    Type: Application
    Filed: August 21, 2013
    Publication date: February 27, 2014
    Applicant: AmebaGone, LLC
    Inventors: Marcin Filutowicz, Katarzyna Dorota Borys, Dean Sanders
  • Publication number: 20140030227
    Abstract: The present invention relates to amoebae (slime molds) and uses thereof. In particular, the present invention relates to the use of amoebae or their environmentally stable spores to treat microbial infections and other uses.
    Type: Application
    Filed: September 27, 2013
    Publication date: January 30, 2014
    Applicant: AMEBAGONE, LLC
    Inventors: Marcin Filutowicz, Katarzyna Dorota Borys
  • Patent number: 8551471
    Abstract: The present invention relates to amoebae (slime molds) and uses thereof. In particular, the present invention relates to the use of amoebae or their environmentally stable spores to treat microbial infections and other uses.
    Type: Grant
    Filed: June 3, 2011
    Date of Patent: October 8, 2013
    Assignee: AmebaGone, LLC
    Inventors: Marcin Filutowicz, Katarzyna Dorota Borys
  • Publication number: 20110300106
    Abstract: The present invention relates to amoebae (slime molds) and uses thereof. In particular, the present invention relates to the use of amoebae or their environmentally stable spores to treat microbial infections and other uses.
    Type: Application
    Filed: June 3, 2011
    Publication date: December 8, 2011
    Applicant: AMEBAGONE, LLC
    Inventors: Marcin Filutowicz, Katarzyna Dorota Borys
  • Publication number: 20060270040
    Abstract: The present invention relates to the field of bacteriology. In particular, the invention relates to novel compositions and methods for altering (e.g., inhibiting) the growth and virulence of populations of pathogenic microorganisms.
    Type: Application
    Filed: May 26, 2005
    Publication date: November 30, 2006
    Applicant: ConjuGon, Inc.
    Inventors: Marcin Filutowicz, Hideki Suzuki
  • Publication number: 20060003454
    Abstract: The present invention relates to compositions comprising conjugation-competent non-dividing cells for delivery of genes to bacterial cells by conjugation. The present invention also relates to methods of making, using, and storing such conjugation competent non-dividing cells.
    Type: Application
    Filed: July 2, 2004
    Publication date: January 5, 2006
    Applicant: ConjuGon, Inc.
    Inventors: Hideki Suzuki, Marcin Filutowicz, Larry Anthony
  • Publication number: 20050181395
    Abstract: The present invention relates to bacterial expression vectors. In particular, the present invention provides tightly-regulated bacterial expression vectors designed for the cloning and expression of toxic proteins, RNA, and metabolites in vivo. The present invention thus provides methods of expressing protein and RNAs that were previously not able to be expressed.
    Type: Application
    Filed: December 13, 2004
    Publication date: August 18, 2005
    Applicant: ConjuGon, Inc.
    Inventors: Larry Anthony, Marcin Filutowicz, Hideki Suzuki
  • Publication number: 20050163757
    Abstract: Novel antimicrobial agents that can serve as replacements to conventional pharmaceutical antibiotics are disclosed. The antimicrobial agents comprise conjugatively transmissible plasmids that kill targeted pathogenic bacteria, but are not harmful to donor bacteria. Two types of lethal transmissible plasmids are disclosed. One type kills recipient bacteria by unchecked (“runaway”) replication in the recipient cells and is prevented from occurring in donor cells. Another type kills recipient bacteria by expressing a gene that produces a product detrimental or lethal to recipient bacterial cells, that gene being prevented from expression in donor cells.
    Type: Application
    Filed: January 24, 2005
    Publication date: July 28, 2005
    Inventor: Marcin Filutowicz